Cinnamaldehyde is a naturally occurring flavonoid that gives the spice cinnamon its flavour and odour. It occurs naturally in the bark of cinnamon trees and other species of the genus Cinnamomum such as camphor and cassia.
Sensitivity to cinnamaldehyde may be identified with a clinical patch test.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Calcium carbimide | The risk or severity of adverse effects can be increased when Calcium carbimide is combined with Cinnamaldehyde. |
| Disulfiram | The risk or severity of adverse effects can be increased when Disulfiram is combined with Cinnamaldehyde. |
| Lidocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Lidocaine. |
| Ropivacaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Ropivacaine. |
| Bupivacaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Bupivacaine. |
| Cinchocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Cinchocaine. |
| Dyclonine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Dyclonine. |
| Procaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Procaine. |
| Prilocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Prilocaine. |
| Proparacaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Proparacaine. |
| Meloxicam | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Meloxicam. |
| Oxybuprocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Oxybuprocaine. |
| Cocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Cocaine. |
| Mepivacaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Mepivacaine. |
| Levobupivacaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Levobupivacaine. |
| Diphenhydramine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Diphenhydramine. |
| Benzocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Benzocaine. |
| Chloroprocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Chloroprocaine. |
| Phenol | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Phenol. |
| Tetrodotoxin | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Tetrodotoxin. |
| Benzyl alcohol | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Benzyl alcohol. |
| Capsaicin | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Capsaicin. |
| Etidocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Etidocaine. |
| Articaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Articaine. |
| Tetracaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Tetracaine. |
| Propoxycaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Propoxycaine. |
| Pramocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Pramocaine. |
| Butamben | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Butamben. |
| Butacaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Butacaine. |
| Oxetacaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Oxetacaine. |
| Ethyl chloride | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Ethyl chloride. |
| Butanilicaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Butanilicaine. |
| Metabutethamine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Metabutethamine. |
| Quinisocaine | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Quinisocaine. |
| Tenofovir alafenamide | The serum concentration of Tenofovir alafenamide can be increased when it is combined with Cinnamaldehyde. |
| Ambroxol | The risk or severity of methemoglobinemia can be increased when Cinnamaldehyde is combined with Ambroxol. |
| Etrasimod | The risk or severity of immunosuppression can be increased when Cinnamaldehyde is combined with Etrasimod. |